- Home
- FWRD vs PRAX Comparison
FWRD vs PRAX Comparison
Compare FWRD & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FWRD
- PRAX
- Stock Information
- Founded
- FWRD 1981
- PRAX 2015
- Country
- FWRD United States
- PRAX United States
- Employees
- FWRD N/A
- PRAX N/A
- Industry
- FWRD Oil Refining/Marketing
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- FWRD Consumer Discretionary
- PRAX Health Care
- Exchange
- FWRD Nasdaq
- PRAX Nasdaq
- Market Cap
- FWRD 634.2M
- PRAX 730.1M
- IPO Year
- FWRD 1993
- PRAX 2020
- Fundamental
- Price
- FWRD $20.72
- PRAX $38.66
- Analyst Decision
- FWRD Hold
- PRAX Strong Buy
- Analyst Count
- FWRD 4
- PRAX 10
- Target Price
- FWRD $32.00
- PRAX $123.80
- AVG Volume (30 Days)
- FWRD 701.9K
- PRAX 527.3K
- Earning Date
- FWRD 05-07-2025
- PRAX 05-12-2025
- Dividend Yield
- FWRD N/A
- PRAX N/A
- EPS Growth
- FWRD N/A
- PRAX N/A
- EPS
- FWRD N/A
- PRAX N/A
- Revenue
- FWRD $2,474,262,000.00
- PRAX $8,553,000.00
- Revenue This Year
- FWRD $8.80
- PRAX N/A
- Revenue Next Year
- FWRD $6.58
- PRAX $2,780.59
- P/E Ratio
- FWRD N/A
- PRAX N/A
- Revenue Growth
- FWRD 80.51
- PRAX 249.53
- 52 Week Low
- FWRD $11.21
- PRAX $30.01
- 52 Week High
- FWRD $40.92
- PRAX $91.83
- Technical
- Relative Strength Index (RSI)
- FWRD 37.57
- PRAX 36.27
- Support Level
- FWRD $20.30
- PRAX $33.10
- Resistance Level
- FWRD $21.94
- PRAX $39.22
- Average True Range (ATR)
- FWRD 1.18
- PRAX 2.45
- MACD
- FWRD 0.51
- PRAX 1.52
- Stochastic Oscillator
- FWRD 71.27
- PRAX 83.99
About FWRD Forward Air Corporation
Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight and Intermodal. The company generates maximum revenue from the Expedited Freight segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in the United States, Canada, and Mexico.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.